Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
ABBV-400 vs Standard Treatment for Colorectal Cancer
Recruiting2 awardsPhase 3
Saint Louis, Missouri
This trial aims to compare the effectiveness and safety of the investigational drug ABBV-400 with the standard treatment for metastatic colorectal cancer. Participants will receive either ABBV-400 or
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service